See more : Network International Holdings plc (NWKLF) Income Statement Analysis – Financial Results
Complete financial analysis of Camlin Fine Sciences Limited (CAMLINFINE.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Camlin Fine Sciences Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Sunrise Energy Metals Limited (SREMF) Income Statement Analysis – Financial Results
- USS Co., Ltd. (USSJF) Income Statement Analysis – Financial Results
- FTAI Infrastructure Inc. (FIP) Income Statement Analysis – Financial Results
- Virgin Galactic Holdings, Inc. (SPCE) Income Statement Analysis – Financial Results
- TeamViewer AG (TMVWF) Income Statement Analysis – Financial Results
Camlin Fine Sciences Limited (CAMLINFINE.BO)
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; pharmaceutical and nutraceutical products from fermentation and plant extraction sources; and performance chemicals, such as hydroquinone and catechol. Its products are used in food and beverage, pet food and animal nutrition, rendering, aqua culture, petrochemical, pharmaceutical, agrochemical, dyes and pigment, biofuel, aroma technical, fragrance, and flavor industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.95B | 16.80B | 14.09B | 11.81B | 10.40B | 8.83B | 7.15B | 5.29B | 4.89B | 5.58B | 5.09B | 3.74B | 3.35B | -21.68M | 1.40B | 1.04B | 794.10M | 470.31M |
| Cost of Revenue | 9.37B | 8.30B | 7.71B | 5.95B | 5.41B | 4.79B | 4.26B | 2.63B | 2.53B | 2.70B | 2.76B | 1.65B | 1.66B | 11.16M | 1.20B | 844.59M | 649.48M | 453.67M |
| Gross Profit | 6.58B | 8.50B | 6.38B | 5.86B | 4.99B | 4.05B | 2.89B | 2.65B | 2.36B | 2.88B | 2.33B | 2.09B | 1.69B | -32.84M | 203.15M | 196.53M | 144.62M | 16.65M |
| Gross Profit Ratio | 41.27% | 50.59% | 45.29% | 49.64% | 47.99% | 45.81% | 40.38% | 50.22% | 48.26% | 51.55% | 45.79% | 55.93% | 50.48% | 151.49% | 14.48% | 18.88% | 18.21% | 3.54% |
| Research & Development | 0.00 | 57.19M | 45.26M | 44.47M | 40.46M | 31.19M | 18.82M | 25.56M | 21.01M | 24.79M | 27.24M | 17.24M | 14.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 422.31M | 417.99M | 423.02M | 304.21M | 316.93M | 214.20M | 170.89M | 204.35M | 117.26M | 103.10M | 0.00 | 59.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 175.43M | 175.19M | 154.22M | 148.89M | 212.06M | 211.00M | 208.29M | 189.25M | 160.60M | 61.47M | 0.00 | 149.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 597.73M | 593.19M | 577.24M | 453.10M | 528.98M | 425.20M | 379.18M | 393.60M | 277.85M | 164.58M | 343.73M | 671.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 5.99B | 44.89M | 50.00M | 31.30M | 3.77M | 72.44M | 16.91M | 94.34M | 8.60M | 0.00 | 0.00 | 0.00 | 166.90M | 91.75M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.58B | 6.93B | 5.32B | 4.27B | 3.97B | 3.60B | 2.95B | 2.50B | 1.59B | 2.10B | 1.75B | 1.68B | 1.46B | -34.16M | 101.90M | 100.43M | 55.98M | 17.69M |
| Cost & Expenses | 16.01B | 15.23B | 13.03B | 10.22B | 9.38B | 8.38B | 7.21B | 5.13B | 4.12B | 4.81B | 4.51B | 3.33B | 3.12B | -23.00M | 1.30B | 945.01M | 705.46M | 471.36M |
| Interest Income | 17.68M | 10.94M | 17.50M | 14.49M | 17.43M | 38.31M | 8.27M | 15.52M | 12.81M | 14.29M | 17.55M | 24.86M | 26.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 676.20M | 390.63M | 292.34M | 395.18M | 271.95M | 278.27M | 276.48M | 249.25M | 192.03M | 183.33M | 188.88M | 201.10M | 166.90M | 91.75M | 67.78M | 57.55M | 49.86M | 22.17M |
| Depreciation & Amortization | 786.06M | 625.12M | 559.65M | 442.94M | 328.02M | 289.93M | 266.54M | 218.03M | 170.55M | 162.46M | 117.86M | 136.13M | 135.74M | 56.46M | 46.70M | 43.42M | 38.33M | 20.84M |
| EBITDA | 487.60M | 1.90B | 1.86B | 1.98B | 1.24B | 885.06M | 275.59M | 463.49M | 915.16M | 929.04M | 713.09M | 534.90M | 364.81M | 1.32M | 147.95M | 139.53M | 126.97M | 19.80M |
| EBITDA Ratio | 3.06% | 11.46% | 12.78% | 16.10% | 11.21% | 7.66% | 2.69% | 7.55% | 18.63% | 15.63% | 12.88% | 14.61% | 10.35% | -6.10% | 10.55% | 13.40% | 15.99% | 4.21% |
| Operating Income | 17.77M | 1.56B | 994.70M | 1.51B | 936.11M | 364.48M | -130.15M | 190.25M | 500.18M | 523.56M | 348.64M | 235.07M | 106.71M | -55.14M | 101.25M | 96.11M | 88.64M | -1.05M |
| Operating Income Ratio | 0.11% | 9.28% | 7.06% | 12.83% | 9.00% | 4.13% | -1.82% | 3.60% | 10.22% | 9.38% | 6.85% | 6.29% | 3.18% | 254.34% | 7.22% | 9.23% | 11.16% | -0.22% |
| Total Other Income/Expenses | -1.01B | -5.68B | -3.69B | -3.43B | -442.07M | -282.12M | -244.11M | -211.19M | -210.65M | -164.83M | -180.19M | -203.23M | 0.00 | 33.27M | -67.78M | -57.55M | -49.86M | -22.17M |
| Income Before Tax | -992.44M | 803.77M | 939.79M | 1.05B | 582.01M | 166.93M | -307.26M | -60.17M | 500.18M | 528.34M | 348.64M | 235.07M | 106.71M | 91.61M | 33.47M | 38.55M | 38.78M | -23.22M |
| Income Before Tax Ratio | -6.22% | 4.78% | 6.67% | 8.90% | 5.60% | 1.89% | -4.30% | -1.14% | 10.22% | 9.46% | 6.85% | 6.29% | 3.18% | -422.61% | 2.39% | 3.70% | 4.88% | -4.94% |
| Income Tax Expense | 56.32M | 405.67M | 336.07M | 397.38M | 283.70M | 136.87M | -67.54M | -15.78M | 141.98M | -22.08M | 61.26M | 83.84M | 69.41M | 17.57M | 22.67M | 17.12M | 13.92M | -4.98M |
| Net Income | -927.53M | 521.06M | 606.78M | 509.63M | 303.19M | 5.77M | -296.43M | -111.74M | 358.24M | 550.27M | 287.13M | 150.96M | 37.93M | 71.08M | 12.11M | 24.46M | 26.09M | -18.24M |
| Net Income Ratio | -5.82% | 3.10% | 4.31% | 4.32% | 2.91% | 0.07% | -4.15% | -2.11% | 7.32% | 9.86% | 5.64% | 4.04% | 1.13% | -327.91% | 0.86% | 2.35% | 3.29% | -3.88% |
| EPS | -5.58 | 3.11 | 4.65 | 4.13 | 2.50 | 0.05 | -2.70 | -1.10 | 3.73 | 5.77 | 3.06 | 1.61 | 0.41 | 0.75 | 0.49 | 0.27 | 0.36 | -0.33 |
| EPS Diluted | -5.58 | 3.07 | 4.56 | 3.68 | 2.50 | 0.05 | -2.64 | -1.10 | 3.71 | 5.75 | 3.04 | 1.60 | 0.41 | 0.74 | 0.49 | 0.27 | 0.36 | -0.33 |
| Weighted Avg Shares Out | 166.27M | 167.32M | 130.58M | 123.45M | 121.25M | 121.24M | 109.90M | 101.58M | 96.13M | 95.32M | 94.06M | 93.71M | 93.22M | 93.06M | 86.78M | 86.72M | 76.45M | 54.51M |
| Weighted Avg Shares Out (Dil) | 166.27M | 169.48M | 133.18M | 138.36M | 121.34M | 121.25M | 112.10M | 101.80M | 96.54M | 95.72M | 94.44M | 94.27M | 94.05M | 93.06M | 87.85M | 86.72M | 77.05M | 54.51M |
Source: https://incomestatements.info
Category: Stock Reports